Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies (Q46773455)

25 December 2017

meta-analysis

0 references

title

Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies (English)

1 reference

25 December 2017

0 references

0 references

0 references

1 reference

Hongmei Zhu

1

1 reference

25 December 2017

Siu Wai Leung

series ordinal

2

1 reference

25 December 2017

publication date

13 February 2015

1 reference

25 December 2017

published in

Diabetologia

1 reference

25 December 2017

volume

58

1 reference

25 December 2017

page(s)

900-911

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-015-3510-2

exact match

0 references

cites work

Epidemiology of diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Role of microRNAs in diabetes and its cardiovascular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Role of microRNAs in plant and animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MicroRNAs as novel regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Regulation of mRNA translation and stability by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MicroRNA-29a is up-regulated in beta-cells by glucose and decreases glucose-stimulated insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MicroRNA expression profiling of human islets from individuals with and without type 2 diabetes: promises and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Circulating miRNA profiles in patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Believe it or not: how much can we rely on published data on potential drug targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Drug development: Raise standards for preclinical cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

A survey on data reproducibility in cancer research provides insights into our limited ability to translate findings from the laboratory to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Diabetes mellitus, a microRNA-related disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

microRNA in the development of diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MicroRNAs and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

The microRNA spectrum in 12 body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MicroRNA expression in human omental and subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Contractile protein expression is upregulated by reactive oxygen species in aorta of Goto-Kakizaki rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Comprehensive miRNome and in silico analyses identify the Wnt signaling pathway to be altered in the diabetic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

miR-375 maintains normal pancreatic alpha- and beta-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MicroRNAs 103 and 107 regulate insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Serum microRNAs are promising novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Secretory mechanisms and intercellular transfer of microRNAs in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

A pancreatic islet-specific microRNA regulates insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

MiR-144 regulates hematopoiesis and vascular development by targeting meis1 during zebrafish development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Roles of microRNA on cancer cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Conducting Meta-Analyses in R with the metafor Package

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3510-2

Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.

21 January 2018

1 reference

12 December 2020

Isoform-specific regulation of adipocyte differentiation by Akt/protein kinase Bα

1 reference

12 December 2020

Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1

1 reference

12 December 2020

Expression and DNA methylation status of microRNA-375 in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.

1 reference

12 December 2020

Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals

1 reference

12 December 2020

Analysis of microRNA expression profile induced by AICAR in mouse hepatocytes

1 reference

12 December 2020

Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis

1 reference

12 December 2020

Insights into insulin-mediated regulation of CYP2E1: miR-132/-212 targeting of CYP2E1 and role of phosphatidylinositol 3-kinase, Akt (protein kinase B), mammalian target of rapamycin signaling in regulating miR-132/-212 and miR-122/-181a expression

1 reference

12 December 2020

Role of regulatory micro RNAs in type 2 diabetes mellitus-related inflammation

1 reference

12 December 2020

10.1007/S00125-015-3510-2

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

25677225

1 reference

25 December 2017